BFRI
Income statement / Annual
Last year (2023), Biofrontera Inc.'s total revenue was $34.07 M,
an increase of 18.82% from the previous year.
In 2023, Biofrontera Inc.'s net income was -$20.13 M.
See Biofrontera Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$34.07 M
|
$28.67 M
|
$24.10 M
|
$18.85 M
|
$26.18 M
|
| Cost of Revenue |
$17.44 M |
$15.19 M |
$12.74 M |
$9.07 M |
$12.41 M |
| Gross Profit |
$16.63 M |
$13.49 M |
$11.36 M |
$9.78 M |
$13.77 M |
| Gross Profit Ratio |
0.49 |
0.47 |
0.47 |
0.52 |
0.53 |
| Research and Development
Expenses |
$77,000.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative
Expenses |
$39.13 M
|
$35.87 M
|
$37.21 M
|
$18.12 M
|
$28.70 M
|
| Selling & Marketing
Expenses |
$0.00
|
$100,000.00
|
$500,000.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$39.13 M
|
$35.87 M
|
$37.21 M
|
$18.12 M
|
$28.70 M
|
| Other Expenses |
$100,000.00 |
$33,000.00 |
$689,000.00 |
$1.25 M |
$5.48 M |
| Operating Expenses |
$39.96 M |
$35.87 M |
$37.21 M |
$18.12 M |
$28.70 M |
| Cost And Expenses |
$56.75 M |
$51.06 M |
$49.95 M |
$27.18 M |
$41.10 M |
| Interest Income |
$132,000.00 |
$175,000.00 |
$16,000.00 |
$28,000.00 |
$25,000.00 |
| Interest Expense |
$600,000.00 |
$195,000.00 |
$344,000.00 |
$2.90 M |
$2.16 M |
| Depreciation &
Amortization |
$1.06 M
|
$1.17 M
|
$540,000.00
|
$562,000.00
|
$667,000.00
|
| EBITDA |
-$18.45 M
|
$934,000.00
|
-$36.76 M
|
-$7.49 M
|
-$8.15 M
|
| EBITDA Ratio |
-0.54 |
-0.74 |
-1.04 |
-0.34 |
-0.33 |
| Operating Income Ratio
|
-0.67
|
-0.78
|
-1.07
|
-0.44
|
-0.57
|
| Total Other
Income/Expenses Net |
$2.56 M
|
$17.97 M
|
-$12.46 M
|
-$2.59 M
|
$3.97 M
|
| Income Before Tax |
-$20.12 M |
-$608,000.00 |
-$37.66 M |
-$10.92 M |
-$10.95 M |
| Income Before Tax Ratio
|
-0.59
|
-0.02
|
-1.56
|
-0.58
|
-0.42
|
| Income Tax Expense |
$14,000.00 |
$32,000.00 |
$56,000.00 |
$64,000.00 |
$33,000.00 |
| Net Income |
-$20.13 M |
-$640,000.00 |
-$37.71 M |
-$10.99 M |
-$10.98 M |
| Net Income Ratio |
-0.59 |
-0.02 |
-1.56 |
-0.58 |
-0.42 |
| EPS |
-13.02 |
-0.61 |
-44.1 |
-18.94 |
-18.09 |
| EPS Diluted |
-13.02 |
-0.61 |
-44.1 |
-18.94 |
-18.09 |
| Weighted Average Shares
Out |
$1.55 M
|
$1.06 M
|
$855,237.00
|
$580,000.00
|
$607,000.00
|
| Weighted Average Shares
Out Diluted |
$1.55 M
|
$1.06 M
|
$855,237.00
|
$580,000.00
|
$607,000.00
|
| Link |
|
|
|
|
|
